Rahman, Eqram https://orcid.org/0000-0002-8443-8338
Sayed, Karim
Rao, Parinitha
Flanagan, Aofie
Garcia, Patricia E.
Chowdhury, Nusrat Jahan
Ioannidis, Sotirios
Nassif, Alexander D.
Webb, William Richard
Peng, Hsien-Li Peter
Goodman, Greg J.
Carruthers, Jean D. A.
Wu, Woffles T. L.
Article History
Received: 1 May 2025
Accepted: 10 July 2025
First Online: 25 August 2025
Declarations
:
: Dr Rahman served as a speaker for Allergan aesthetics an Abbvie Company (Irvine, CA); Dr Rao, Dr Garcia, Dr Ioannidis is a speaker for Allergan aesthetics an Abbvie Company (Irvine, CA); Dr Sayed is a consultant to, speaker for, and has received honoraria from L’oréal/Skinceuticals, Teoxane, Lutronic Cynosure and Allergan, an AbbVie Company; Dr Peng has served as a speaker or consultant for allergan, Lumenis, Candela, Cynosure, Quanta; Dr Goodman is a speaker, investigator, and consultant for Allergan Aesthetics an Abbvie Company. (Irvine, Calif.) and Galderma (Lausanne, Switzerland). He is the President of Australian Society of Cosmetic Dermatologists. Dr Carruthers has been a consultant and researcher for Alastin, Appiell, Allergan Aesthetics, an AbbVie Company, Avari, Bonti (now with Allergan/AbbVie), Evolus, Fount Bio, In Mode, Jeune Aesthetics, Merz, and Revance Biopharma and also own shares in Galderma. She is an author and editor for Elsevier and “Up to Date” Neuromodulators and Fillers, as well as an assistant editor for Dermatologic Surgery; Dr Wu is a speaker and consultant for Allergan Aesthetics an Abbvie Company, Merz Pharmaceuticals GmbH; Dr Flanagan, Dr Chowdhury, Dr Webb and Dr Nassif has nothing to disclose. The authors declare that they have no conflicts of interest to disclose in relation to this manuscript.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, informed consent is not required.